Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs FYU-981 (Primary) ; Topiroxostat
- Indications Hyperuricaemia
- Focus Pharmacodynamics
- Sponsors Fuji Yakuhin
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.
- 21 Jul 2016 New trial record